Drugs / Trimethobenzamide

Regulatory milestones approvals, filings & regulatory actions · 2 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Label expansion US (FDA) TIGAN — 2001-12-13 fda.gov ↗
Approved US (FDA) TIGAN — 1974-07-12 fda.gov ↗

Trials 2

19731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 42 trials · 1 missed
Phase 4 NCT07681076 Sep → Nov 2026 expected — Karuna Therapeutics, Inc. Recruiting No outcome recorded
Phase 4 NCT00489255 May 2007 → Dec 2011 Parkinson disease Ipsen Completed Missed primary
Comparator or background therapy3 trials
Phase 1 NCT02373072 Background Mar 2015 → Feb 2016 Parkinson disease Pfizer Completed No outcome recorded
Phase 1 NCT02262767 Background Nov → Dec 2014 — Pfizer Completed No outcome recorded
Phase 4 NCT01770145 Background Dec 2012 → Apr 2014 Parkinson disease, akinetopsia, movement disorder Supernus Pharmaceuticals Completed No outcome recorded

Evidence & citations 10 cited values

Every value below carries the sentence it was read from. 6 sources stand behind the page.

FieldValueCited text
Known as trimethobenzamide “Tigan® (trimethobenzamide) in preventing nausea and vomiting when initiating therapy with Apokyn® (apomorphine)” NCT00489255 ↗
3

NCT01770145 ↗

NCT07681076 ↗

NCT02262767 ↗

Known as Ametik damla ChEMBL registry synonym — accepted as the source's own label CHEMBL1201256 ↗
Known as NSC-37882 ChEMBL registry synonym — accepted as the source's own label CHEMBL1201256 ↗
Known as Tigan “Tigan® (trimethobenzamide) in preventing nausea and vomiting when initiating therapy with Apokyn® (apomorphine)” NCT00489255 ↗
Known as Trimethobenzamide hcl ChEMBL registry synonym — accepted as the source's own label CHEMBL1201256 ↗
Known as Trimethobenzamide Hydrochloride ClinicalTrials.gov intervention name — accepted as the source's own label NCT02373072 ↗
Known as Trimethobenzamide hydrochloride preservative free ChEMBL registry synonym — accepted as the source's own label CHEMBL1201256 ↗
Known as Trimetobenzamida ChEMBL registry synonym — accepted as the source's own label CHEMBL1201256 ↗
Modality Small molecule — CHEMBL1201256 ↗
Route Oral “Oral capsule, 300mg three times daily” NCT00489255 ↗